Every 8-K that Agilent Technologies Inc. (A) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow A and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full A filings page.
Agilent Technologies, Inc. (A) reported governance changes to its board of directors. On September 2, 2026, longtime director and board chair Boon Hwee Koh notified the company of his decision to retire from the board, effective September 4, 2026, after roughly 23 years of service; the company states his decision was not due to any disagreement regarding operations, policies, or practices.
Effective September 4, 2026, the board appointed Glenn Boehnlein, age 64 and former Vice President and Chief Financial Officer of Stryker Corporation, as a Class III director, and named him to the Audit and Finance Committee and the Compensation Committee. The board determined that he is independent under New York Stock Exchange corporate governance standards and that he qualifies as an “audit committee financial expert.” Separately, the board elected Dow R. Wilson, a director since 2018, to serve as board chair.
Agilent describes Boehnlein’s background in senior finance roles at Stryker, prior CFO and audit experience, and current board roles at Inogen Inc. and Sutter Health. He will receive the company’s standard non-employee director compensation and enter into Agilent’s standard indemnification agreement. Agilent also notes that it generated $6.95 billion in revenue in fiscal 2025 and employs about 18,000 people worldwide.
Agilent Technologies, Inc. (A) reported strong results for the third fiscal quarter ended July 31, 2026, and raised its full-year 2026 outlook. Revenue was $1.88 billion, up 8.1% reported and 7.3% core compared with the same quarter in 2025. GAAP operating margin was 23.6%, expanding 290 basis points year-over-year, while non-GAAP operating margin was 28.3%, up 320 basis points, including a net benefit of about 110 basis points from tariff refunds.
GAAP net income was $362 million, or $1.28 per share, up about 8% year-over-year. Non-GAAP net income was $459 million and non-GAAP EPS was $1.62, both including a $17 million and $0.06 per-share net benefit from tariff refunds, and up roughly 18% versus 2025. All three segments grew: Life Sciences and Diagnostics revenue rose 11%, Agilent CrossLab 6%, and Applied Markets 7%, each with margin expansion.
For fiscal 2026, Agilent now expects revenue of $7.49–$7.51 billion (up 7.8–8.1% reported, 5.8–6.0% core) and non-GAAP EPS of $6.18–$6.21, both higher than prior guidance and including the $0.06 tariff benefit already realized. Fourth-quarter 2026 revenue is guided to $1.98–$2.0 billion with non-GAAP EPS of $1.71–$1.74, excluding any future tariff refunds.
Agilent Technologies has closed a private sale of $600 million in 4.900% Senior Notes due 2032 to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S. The notes priced at 99.968% of principal, mature on January 15, 2032 and pay interest semi-annually each January 15 and July 15, starting in 2027.
The notes are senior unsecured obligations and can be redeemed early at a make-whole premium before December 15, 2031, and at par plus interest on or after that date. If a Change of Control Repurchase Event occurs, Agilent must offer to repurchase the notes at 101% of principal plus interest.
Under a Registration Rights Agreement, Agilent will use commercially reasonable efforts to exchange the notes for registered notes or, if needed, register resales. If it does not meet these registration obligations by June 25, 2027 or a registration default continues, the notes’ interest rate will increase by up to 0.50% per year until cured.
Agilent Technologies reported strong second-quarter fiscal 2026 results, with revenue of $1.83 billion, up 10% year-over-year and 6.3% on a core basis. GAAP net income was $339 million, or $1.20 per share, up 60% from the prior-year quarter, while non-GAAP EPS rose 14% to $1.49.
All segments grew, led by Applied Markets up 14% and Life Sciences and Diagnostics up 12%. The company raised its full-year 2026 outlook, guiding revenue to $7.39–$7.49 billion and non-GAAP EPS to $6.00–$6.10, and issued Q3 revenue guidance of $1.83–$1.85 billion. Agilent also named Tim Downs as Vice President and Chief Accounting Officer, with a $400,000 base salary, 60% target bonus, a $175,000 cash sign-on bonus, and a $1.0 million RSU grant vesting over four years.
Agilent Technologies, Inc. reported a leadership change in its top legal role. Bret DiMarco, previously Senior Vice President, Chief Legal Officer and Secretary, resigned from those positions when the company appointed Michael Buckner as Chief Legal Officer, effective May 4, 2026, under a previously disclosed transition agreement.
DiMarco will remain employed as a Special Advisor to support the transition through December 1, 2026. Agilent highlights Buckner’s extensive experience leading global legal teams and complex M&A, antitrust, and regulatory matters. As broader context, Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs about 18,000 people worldwide.
Agilent Technologies, Inc. filed an amended report to correct an EDGAR header, clarifying that the disclosure is made under Item 5.02, which covers director and officer changes and compensation arrangements. The underlying disclosure is unchanged.
The company describes a Transition and General Release Agreement with Senior Vice President, Chief Legal Officer and Secretary Bret DiMarco. He will resign from these roles on the earlier of the start date of a new Chief Legal Officer or September 30, 2026, then continue as a Special Advisor providing transitional assistance through December 1, 2026. As Special Advisor, he will receive base salary at an annualized rate of $350,000, remain eligible for group health and welfare plans, and continue vesting in existing equity awards, but will not receive additional equity grants or a 2026 annual bonus. After his Special Advisor service ends, and subject to a supplemental release of claims, he will receive a lump sum equal to one times his current base salary and target bonus, reduced by the base salary already paid for the Special Advisor period.
Agilent Technologies, Inc. announced a leadership transition for its top legal executive. Senior Vice President, Chief Legal Officer and Secretary Bret DiMarco entered into a Transition and General Release Agreement under which he will resign from these roles upon the earlier of the start date of a new Chief Legal Officer or September 30, 2026.
DiMarco will then serve as a Special Advisor through December 1, 2026, receiving an annualized base salary of $350,000, continued eligibility for group health and welfare plans, and ongoing vesting of existing equity awards. He will not receive new equity grants or an annual bonus for the 2026 fiscal year.
After his Special Advisor service ends, and contingent on a supplemental release of claims becoming effective, he will receive a lump-sum payment equal to one times his current base salary and target bonus, reduced by the base salary already paid for his Special Advisor service.
Agilent Technologies, Inc. reported results of its annual stockholder meeting and governance changes. Stockholders approved a Fourth Amended and Restated Certificate of Incorporation that will declassify the board of directors over a three-year period. The board simultaneously adopted Fourth Amended and Restated Bylaws to align with this phased declassification, including allowing stockholders to remove directors with or without cause beginning with the 2029 annual meeting, when the board will no longer be classified.
At the meeting, about 250.3 million shares of common stock, representing approximately 88% of shares outstanding, were represented. Stockholders elected four directors to three-year terms, approved on a non-binding basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditor for the 2026 fiscal year. They also approved the charter amendment to declassify the board.
Agilent Technologies, Inc. reported that Rodney Gonsalves, its Vice President, Corporate Controller and Principal Accounting Officer, plans to retire in January 2027, with the exact date to be set later. The company states that his departure is not related to any disagreement regarding accounting practices, financial statements, internal controls, or operations.
By giving advance notice, Agilent plans to conduct a comprehensive search for his successor and have Mr. Gonsalves help with an orderly transition of his duties to the new principal accounting officer.
Agilent Technologies reported first-quarter fiscal 2026 revenue of $1.80 billion, up 7.0% reported and 4.4% core versus the prior year. GAAP net income was $305 million, or $1.07 per share, slightly below $1.11 a year ago, while non-GAAP net income rose to $386 million and non-GAAP EPS to $1.36, up 4%.
The Life Sciences and Diagnostics Markets segment generated $679 million of revenue, the Agilent CrossLab segment $758 million, and the Applied Markets segment $361 million, with all three showing mid-single to high-single-digit reported growth. Operating margins by segment remained healthy, led by CrossLab at 31.6%.
For fiscal 2026, Agilent now expects revenue of $7.3–$7.5 billion, representing 5.5%–7.5% reported growth and 4%–6% core growth, and projects non-GAAP EPS of $5.90–$6.04. Second-quarter 2026 revenue is guided to $1.79–$1.82 billion with non-GAAP EPS of $1.39–$1.42, implying continued mid- to high-single-digit growth.
Agilent Technologies, Inc. filed a Form 8-K to announce that it has released financial results for its fourth fiscal quarter ended October 31, 2025, via a press release furnished as Exhibit 99.1. The company highlights that this press release includes both GAAP and non-GAAP financial measures that management uses to evaluate segment and enterprise performance and to compare results with prior periods and competitors.
Agilent explains that its non-GAAP information excludes items such as restructuring and amortization and is intended to give investors additional insight into operational performance, while not serving as a substitute for U.S. GAAP. The company notes it has historically provided similar non-GAAP metrics and that further explanation of these measures is included in Exhibit 99.1.
Agilent Technologies appointed Adam S. Elinoff as Senior Vice President and Chief Financial Officer, effective November 17, 2025, replacing interim CFO Rodney Gonsalves, who continues as Vice President, Corporate Controller and Principal Accounting Officer.
The compensation package includes a base salary of $700,000 and eligibility for an annual bonus targeted at 80% of base salary. Equity awards comprise fiscal 2025 RSUs with a target value of $1,100,000 and performance-based RSUs for the fiscal 2026–2028 period with a target value of $1,650,000, effective November 18, 2025. The Committee also approved a one-time cash bonus of $800,000 subject to repayment if employment ends within 12 months, plus sign-on RSUs targeted at $560,000 and performance-based RSUs targeted at $840,000.
RSUs vest over four years. Performance-based RSUs vest on October 31, 2028 with payout ranging from 0% to 200% based on Company performance. Agilent furnished a press release as Exhibit 99.1.
Agilent Technologies filed a Form 8-K reporting that on August 27, 2025 it issued a press release announcing financial results for the third fiscal quarter ended July 31, 2025. The filing states the press release is attached as Exhibit 99.1 and that the Exhibit is furnished, not "filed." The company explains it provides non-GAAP financial measures to supplement GAAP results, saying these measures exclude items such as restructuring and amortization and are used by management to evaluate segment and enterprise performance. The filing notes non-GAAP reconciliations and additional explanation appear in Exhibit 99.1.
Agilent Technologies reported the resignation of Robert W. McMahon from his role as Senior Vice President and Chief Financial Officer and named Rodney Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer.
The Compensation Committee approved a bi-weekly salary stipend of $8,654 effective July 31, 2025 while Mr. Gonsalves serves as interim CFO and a grant of restricted stock units in a target amount of $1,000,000, subject to Agilent's standard equity award terms under its 2018 Stock Plan.
Agilent Technologies (NYSE: A) filed an 8-K disclosing that Chief Financial Officer Robert W. McMahon will resign effective 31 July 2025. The company states the departure is not linked to any disagreement over accounting, financial statements, internal controls, or operations.
The board has appointed Rodney Gonsalves—currently Vice President, Corporate Controller and Principal Accounting Officer—as interim CFO and Principal Financial Officer, also effective 31 July 2025. Gonsalves will retain his existing positions, and the filing notes no related-party transactions requiring disclosure under Regulation S-K Item 404(a).
A press release announcing the leadership change was issued on 15 July 2025 and furnished as Exhibit 99.1. Apart from the management transition, the filing contains no financial updates, guidance revisions, or strategic transactions.